Home › Pulmonary Fibrosis › North Carolina
Pulmonary Fibrosis clinical trials in North Carolina
4 studies for Pulmonary Fibrosis are looking for participants at sites in North Carolina.
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- UNC Chapel Hill, Chapel Hill
- Duke University, Durham
- Pulmonix LLC, Greensboro
- and 1 more
RecruitingObservational study
Ages 21 and older · All sexes · Updated Nov 12, 2026 · NCT01915511Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Pulmonix LLC, Greensboro
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Oct 23, 2026 · NCT07284602H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 28, 2026 · NCT06325696Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Southeastern Research Center, Winston-Salem
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.